Restatement of Previously Issued Condensed Consolidated Financial Statements (Tables)
|
3 Months Ended |
9 Months Ended |
12 Months Ended |
Sep. 30, 2014 |
Sep. 30, 2015 |
Sep. 30, 2014 |
Dec. 31, 2014 |
| Schedule of Outstanding Warrants, Restatement [Table Text Block] |
|
|
Issued to Investors on July 28, 2010, entitling the holders to purchase
1,034,996
common shares in the Company at an exercise price of $9.00
per common share up to and including July 27, 2017
|
|
1,034,996
|
|
| |
|
|
|
|
Issued to Investors on October 25, 2013, entitling the holders to purchase
1,250,000
common shares in the Company at an exercise price of $2.30
per common share up to and including April 24, 2021
|
|
1,117,178
|
|
| |
|
|
|
|
Issued to Investors on November 17, 2014, entitling the holders to purchase
2,734,590
common shares in the Company at an exercise price of $2.31
per common share up to and including May 16, 2022
|
|
2,734,590
|
|
| |
|
|
|
| Total |
|
4,886,764
|
|
|
|
|
| Schedule of Consolidated Balance Sheet, Restated [Table Text Block] |
|
|
|
| |
|
As of December 31, 2014
|
|
|
Consolidated Balance Sheet Data:
|
|
As Previously
Reported
|
|
|
Adjustment
|
|
|
As Restated
|
|
| Warrant liability |
$ |
-
|
|
|
4,633,312
|
|
$ |
4,633,312
|
|
| Total liabilities |
|
653,669
|
|
|
4,633,312
|
|
|
5,286,981
|
|
| Additional paid-in capital |
|
81,276,339
|
|
|
(10,474,875
|
) |
|
70,801,464
|
|
| Accumulated deficit |
|
(75,894,854
|
) |
|
5,841,563
|
|
|
(70,053,291
|
) |
| Total stockholders’ equity |
$ |
5,399,568
|
|
|
(4,633,312
|
) |
$ |
766,256
|
|
|
| Schedule of Consolidated Statement of Operations, Restated [Table Text Block] |
| |
|
Three Months Ended September 30, 2014
|
|
| |
|
As Previously
Reported
|
|
|
Adjustment
|
|
|
As Restated
|
|
|
Consolidated Statement of Operations Data
:
|
|
|
|
|
|
|
|
|
|
| Warrant revaluation |
$ |
-
|
|
|
857,308
|
|
$ |
857,308
|
|
| Loss from operations before income taxes |
|
(761,312
|
) |
|
857,308
|
|
|
95,996
|
|
| Net income (loss) |
|
(761,312
|
) |
|
857,308
|
|
|
95,996
|
|
| Net income (loss) per share, basic and diluted |
$ |
(0.05
|
) |
|
0.06
|
|
$ |
0.01
|
|
|
|
| |
|
Nine Months Ended September 30, 2014
|
|
| |
|
As Previously
Reported
|
|
|
Adjustment
|
|
|
As Restated
|
|
|
Consolidated Statement of Operations Data:
|
|
|
|
|
|
|
|
|
|
| Warrant revaluation |
$ |
-
|
|
|
(1,213,051
|
) |
$ |
(1,213,051
|
) |
| Loss from operations before income taxes |
|
(3,850,342
|
) |
|
(1,213,051
|
) |
|
(5,063,393
|
) |
| Net loss |
|
(3,850,342
|
) |
|
(1,213,051
|
) |
|
(5,063,393
|
) |
| Net loss per share, basic and diluted |
$ |
(0.26
|
) |
|
(0.08
|
) |
$ |
(0.34
|
) |
|
|
| Schedule of Consolidated Cash Flows, Restated [Table Text Block] |
|
|
| |
|
Nine Months Ended September 30, 2014
|
|
| |
|
As Previously
Reported
|
|
|
Adjustment
|
|
|
As Restated
|
|
|
Consolidated Cash Flows Data:
|
|
|
|
|
|
|
|
|
|
| Net loss |
$ |
(3,850,342
|
) |
|
(1,213,051
|
) |
$ |
(5,063,393
|
) |
| Warrant revaluation |
$ |
-
|
|
|
1,213,051
|
|
$ |
1,213,051
|
|
|
|